FDA Adverse Event Injury Summary report: N

PARADIGM REAL-TIME REVEL INSULIN INFUSION PUMP

MDR report key: 4141711 · Received October 4, 2014

Report

Report Number
2032227-2014-33282
Event Type
Injury
Date Received
October 4, 2014
Date of Event
September 4, 2014
Report Date
September 4, 2014
Manufacturer
MEDTRONIC PUERTO RICO OPERATIONS CO.
Product Code
OYC
PMA / PMN Number
P980022
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MI
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

THIS MDR RELATED TO THE PUERTO RICO MANUFACTURING SITE HAS BEEN ASSIGNED A MEDWATCH NUMBER FROM THE MEDTRONIC MINIMED (B)(4). CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. NO CONCLUSION CAN BE DRAWN AT THIS TIME. WE THEREFORE CONSIDER THIS REPORT COMPLETE TO THE BEST OF OUR KNOWLEDGE.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE CUSTOMER HAD HIGH BLOOD GLUCOSE LEVELS, EXCESSIVE NO DELIVERY ALARMS, AND A LOW RESERVOIR ALARM ON THE INSULIN PUMP. CUSTOMER STATED THAT HIS BLOOD GLUCOSE WENT OVER 600 MG/DL AND HE CHANGED TO A NEW SITE AND HE CHANGED TO A NEW INFUSION SET. CUSTOMER'S BLOOD GLUCOSE LEVEL WAS CURRENTLY 345 MG/DL. CUSTOMER TREATED WITH THE PUMP AND DID A BOLUS. CUSTOMER HAD NO SYMPTOMS OF HIGH BLOOD GLUCOSE LEVELS. CUSTOMER WAS ASSISTED WITH REMOVING THE RESERVOIR AND REWINDING THE PUMP. INSULIN EXITED AND PUMP SETTINGS WERE REVIEWED AND FOUND TO BE CORRECT. CUSTOMER DID NOT HAVE A TUBING CLAMP AND WILL NEED TO CALL BACK TO CONTINUE TROUBLESHOOTING ONCE HE RECEIVES THE TUBING CLAMP. CUSTOMER WAS ADVISED TO CHANGE THE ENTIRE SET, RESERVOIR, AND INSULIN. CUSTOMER WAS ALSO ADVISED TO TREAT PER HEALTH CARE PROFESSIONAL'S INSTRUCTION. NO ADDITIONAL INFORMATION PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
621286 PARADIGM REAL-TIME REVEL INSULIN INFUSION PUMP INSULIN INFUSION PUMP / SENSOR AUGMENTED OYC MEDTRONIC PUERTO RICO OPERATIONS CO. MMT-723NAP

Patients

Seq Age Sex Outcome Treatment
1 34 YR